Virasoft

About:

is a pioneering startup specializing in the field of cancer diagnosis and research through the integration of digital pathology and AI.

Website: https://www.virasoft.com

Twitter/X: VirasoftTR

Top Investors: TT Ventures, Turkey Development Fund, Diffusion Capital Partners, Ak Portfoy, Eczacıbasi Momentum

Description:

Virasoft has been making significant strides in both the US and global markets, establishing a solid presence by serving tens of institutions and catering to hundreds of thousands of patients annually. Their relentless dedication to advancing the field is evident in our commitment to facilitating the workflow and decision-making processes of pathologists and researchers through cutting-edge digital transformation and AI-powered decision-support algorithms. Notably, we leverage a vast dataset of millions of glass slides annually to fuel the development of our AI models.

Total Funding Amount:

$4.81M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2017-01-01

Contact Email:

samet(AT)virasoft.com

Founders:

Gökhan Hatipoğlu, Samet Ayalti

Number of Employees:

11-50

Last Funding Date:

2021-09-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai